Cetera Investment Advisers Edwards Lifesciences Corp Transaction History

Cetera Investment Advisers

$42.2 Billion
Q2 2024

A detailed history of Cetera Investment Advisers transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cetera Investment Advisers holds 140,686 shares of EW stock, worth $9.26 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

140,686

Previous 145,840 3.53%

Holding current value

$9.26 Million

Previous $13.9 Million 6.75%

% of portfolio

0.03%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 22, 2024	SELL	$84.3 - $94.31 $434,482 - $486,073	-5,154 Reduced 3.53%	140,686 $13 Million
Q1 2024 May 24, 2024	BUY	$72.54 - $95.56 $8.86 Million - $11.7 Million	122,118 Added 514.79%	145,840 $13.9 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $1.75 Million - $2.3 Million	-24,080 Reduced 50.37%	23,722 $2.27 Million
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $124,777 - $157,230	-2,022 Reduced 4.06%	47,802 $3.64 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $85,768 - $115,604	1,238 Added 2.55%	49,824 $3.45 Million
Q2 2023 Aug 09, 2023	BUY	$81.41 - $94.33 $198,558 - $230,070	2,439 Added 5.29%	48,586 $4.58 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $129,063 - $146,878	-1,738 Reduced 3.63%	46,147 $3.82 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $971,021 - $1.24 Million	-14,217 Reduced 22.89%	47,885 $3.57 Million
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $2.3 Million - $3 Million	27,941 Added 81.79%	62,102 $5,000
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $43,163 - $64,006	-499 Reduced 1.44%	34,161 $3.25 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $63,317 - $79,699	621 Added 1.82%	34,660 $4.08 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $167,639 - $205,951	1,576 Added 4.85%	34,039 $4.41 Million
Q3 2021 Nov 16, 2021	SELL	$102.91 - $122.75 $11,525 - $13,748	-112 Reduced 0.34%	32,463 $3.68 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $1.47 Million - $1.83 Million	17,492 Added 115.97%	32,575 $3.37 Million
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $988,142 - $1.14 Million	-12,559 Reduced 45.43%	15,083 $1.26 Million
Q4 2020 Feb 17, 2021	BUY	$71.69 - $91.23 $1.71 Million - $2.18 Million	23,844 Added 627.8%	27,642 $2.52 Million
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $166,228 - $216,326	-2,474 Reduced 39.45%	3,798 $303,000
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $242,876 - $324,805	4,221 Added 205.8%	6,272 $433,000
Q1 2020 May 08, 2020	SELL	$52.41 - $81.0 $681 - $1,053	-13 Reduced 0.63%	2,051 $387,000
Q4 2019 Feb 10, 2020	BUY	$71.7 - $82.09 $34,846 - $39,895	486 Added 30.8%	2,064 $481,000
Q3 2019 Nov 06, 2019	BUY	$61.55 - $75.43 $97,125 - $119,028	1,578 New	1,578 $346,000

Others Institutions Holding EW

# of Institutions

1,340

Shares Held

467M

Call Options Held

2.56M

Put Options Held

2.56M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Edwards Lifesciences Corp Transaction History